MOTS-c is a synthetic mitochondrial-derived peptide encoded by the mitochondrial 12S rRNA gene, supplied as a lyophilised powder in a sealed single-use vial for laboratory and analytical research purposes only. Stock is held and dispatched from Australia with tracking, typically within 1-2 business days of order.
Specifications - Compound: MOTS-c (Mitochondrial Open Reading Frame of the 12S rRNA type-c). Format: lyophilised powder. Quantity: 10mg per vial. Purity: 98% minimum, analytically verified. Appearance: white lyophilised powder. Storage: 2-8 degrees C, sealed, protected from light. Intended use: laboratory research only.
Research context - MOTS-c belongs to a class of peptides encoded within mitochondrial DNA rather than the nuclear genome, which makes it structurally distinct from the majority of research peptides. Laboratory investigation concentrates on metabolic pathway signalling in cultured cell models, AMPK pathway interaction studies, and research into mitochondrial-nuclear communication. Its mitochondrial origin makes it a compound of particular interest in cellular energy metabolism research and in studies examining how mitochondrial-derived peptides differ in behaviour from nuclear-encoded equivalents. Genesis Peptides supplies MOTS-c in lyophilised form to preserve compound integrity during transport and storage.
Handling and storage - Store the sealed vial refrigerated at 2-8 degrees C and protect it from heat and light. Reconstitute using bacteriostatic water and follow established laboratory handling protocols. Reconstituted material has a materially shorter stable life than lyophilised powder and should be kept refrigerated.
Compliance notice - This product is supplied strictly for laboratory research use only. Not for human consumption, veterinary use, or therapeutic application. Not listed with the TGA. Genesis Peptides does not provide medical, therapeutic, or clinical guidance.